Arrowhead Pharmaceuticals Inc.

XNAS:ARWR 4:00:00 PM EDT

59.20

-1.47 (-2.42%)

6:56:35 PM EDT: $59.00 -0.20 (-0.34%)

Market Cap (Intraday)	8.29B
Current PE	40.99
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$71.51 Million
Adjusted EPS	-$1.04

See more estimates

10-Day MA	$62.06
50-Day MA	$65.38
200-Day MA	$39.66

See more pivots

Arrowhead Pharmaceuticals Inc. Stock, XNAS:ARWR

177 East Colorado Boulevard, Suite 700, Pasadena, California 91105

United States of America

Phone: +1.626.304.3400

Number of Employees: 609

http://www.arrowheadpharma.com

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.